CD4+CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade

Journal of Experimental Medicine

Volumn 193, Issue 11, 2001, Pages 1311-1317

  Taylor, Patricia A ^a   Noelle, Randolph J ^b   Blazar, Bruce R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

IL 2 receptor chain (CD25); In vivo animal models; Regulatory T cell; Tolerance; Transplantation

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ANIMAL CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; IMMUNOREGULATION; MIXED LEUKOCYTE CULTURE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD4; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CD40 LIGAND; GRAFT VS HOST DISEASE; IMMUNE TOLERANCE; IMMUNOCONJUGATES; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 0035806276     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.11.1311     Document Type: Article

References (28)

1. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
2. Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells
3. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
4. Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells
5. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment
6. A cell culture model for T lymphocyte clonal anergy
7. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation
8. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice
9. Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning
10. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
11. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand
12. + T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses
13. + T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody
14. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses
15. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
16. Regulatory T cells in autoimmmunity
17. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
18. + T cells: A common basis between tumor immunity and autoimmunity
19. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
20. + immunoregulatory T cells is antigen nonspecific
21. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
22. + regulatory cells that control intestinal inflammation
23. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement
24. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells
25. + T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β
26. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
27. The role of donor and recipient B7-1 (CD80) in allograft rejection
28. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates